Skip to main content
SpringerLink
Log in

Exposition aux produits chimiques dans les unités de soins néonatals — Exemple des phtalates

Chemical exposure in the neonatal care units — The phthalates concerns

  • Mise au Point / Update
  • Published:
Revue de médecine périnatale

Résumé

Alors que les préoccupations de santé environnementale ne cessent de croître dans le public, les médias et les instances politiques, ces questions n’épargnent pas le domaine des soins. En néonatologie, ces questions peuvent se révéler particulièrement critiques compte tenu de la grande vulnérabilité des patients. Parmi les risques environnementaux liés aux soins des nouveau-nés, le risque chimique, souvent latent et peu documenté, s’avère complexe à appréhender. Cette revue propose d’aborder cette problématique autour d’une vignette clinique questionnant l’exposition aux phtalates, particulièrement fréquente dans les unités de soins néonatals. Loin d’être résolus, les dilemmes que ces questions soulèvent ne doivent pas être ignorés.

Abstract

Although environmental health concerns are growing in the public, media, and political circles, these issues are also relevant in the field of medical care. In neonatology, these issues may be particularly critical given the high vulnerability of patients. Among the environmental risks associated with newborn care, the chemical risk, often latent and poorly documented, is complex to approach. This review addresses this problem through a clinical example questioning the exposure to phthalates, particularly important in the neonatal care units. Far from being resolved, the dilemmas that these questions raise should not be ignored.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

ANSM:

Agence nationale de sécurité du médicament et des produits de santé

DEHP:

di(2-éthylhexyl)phtalate

DM:

dispositif médical

PVC:

polychlorure de vinyle

REACH:

Registration, Evaluation, Authorization and restriction of CHemicals

Références

  1. Ancel PY, Goffinet F, EPIPAGE-2 Writing Group, et al (2015) Survival and morbidity of preterm children born at 22 through 34 weeks’ gestation in France in 2011: results of the EPIPAGE- 2 cohort study. JAMA Pediatr 169:230–8

    Article  PubMed  Google Scholar 

  2. Santos J, Pearce SE, Stroustrup A (2015) Impact of hospitalbased environmental exposures on neurodevelopmental outcomes of preterm infants. Curr Opin Pediatr 27:254–60

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kuhn P, Zores C, Astruc D, et al (2011) Sensory system development and the physical environment of infants born very preterm. Arch Pediatr 18:s92–S102

    Article  PubMed  Google Scholar 

  4. Mitro SD, Johnson T, Zota AR (2015) Cumulative chemical exposures during pregnancy and early development. Curr Environ Health Rep 2:367–78

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Martinez-Arguelles DB, Papadopoulos V (2016) Prenatal phthalate exposure: epigenetic changes leading to lifelong impact on steroid formation. Andrology 4:573–84

    Article  CAS  PubMed  Google Scholar 

  6. Mikołajewska K, Stragierowicz J, Gromadzińska J (2015) Bisphenol A — Application, sources of exposure and potential risks in infants, children and pregnant women. Int J Occup Med Environ Health 28:209–41

    PubMed  Google Scholar 

  7. Fischer CJ, Bickle Graz M, Muehlethaler V, et al (2013) Phthalates in the NICU: is it safe? J Paediatr Child Health 49:E413–E9

    Article  PubMed  Google Scholar 

  8. Food Drug Association (2002) Public Health Notification. PVC Devices containing the plasticizer DEHP [Internet]. Available from: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm062182.htm

    Google Scholar 

  9. Weuve J, Sánchez BN, Calafat AM, et al (2006) Exposure to phthalates in neonatal intensive care unit infants: urinary concentrations of monoesters and oxidative metabolites. Environ Health Perspect 114:1424–31

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Mallow EB, Fox MA (2014) Phthalates and critically ill neonates: device-related exposures and non-endocrine toxic risks. J Perinatol 34:892–7

    Article  CAS  PubMed  Google Scholar 

  11. Martino-Andrade AJ, Chahoud I (2010) Reproductive toxicity of phthalate esters. Mol Nutr Food Res 54:148–57

    Article  CAS  PubMed  Google Scholar 

  12. Philippat C, Mortamais M, Chevrier C, et al (2012) Exposure to phthalates and phenols during pregnancy and offspring size at birth. Environ Health Perspect 120:464–70

    Article  CAS  PubMed  Google Scholar 

  13. Polańska K, Ligocka D, Sobala W, Hanke W (2016) Effect of environmental phthalate exposure on pregnancy duration and birth outcomes. Int J Occup Med Environ Health 29:683–97

    Article  PubMed  Google Scholar 

  14. Bickle Graz M, Tolsa JF, Fischer Fumeaux C (2015) Phthalates and neurodevelopmental toxicity: a review of the evidence. In: Owen M (ed) Phthalates: health effects, detection and exposure prevention. Nova Science Publisher, New York, pp 1–28 (Chemistry Research and Applications)

    Google Scholar 

  15. Kavlock R, Barr D, Boekelheide K, et al (2006) NTP-CERHR expert panel update on the reproductive and developmental toxicity of di(2-ethylhexyl)phthalate. Reprod Toxicol Elmsford N 22: 291–399

    Article  Google Scholar 

  16. Roth B, Herkenrath P, Lehmann HJ, et al (1988) Di-(2-ethylhexyl)-phthalate as plasticizer in PVC respiratory tubing systems: indications of hazardous effects on pulmonary function in mechanically ventilated, preterm infants. Eur J Pediatr 147:41–6

    Article  CAS  PubMed  Google Scholar 

  17. Vetrano AM, Laskin DL, Archer F, et al (2010) Inflammatory effects of phthalates in neonatal neutrophils. Pediatr Res 68:134–9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Strømmen K, Lyche JL, Blakstad EW, et al (2016) Increased levels of phthalates in very low birth weight infants with septicemia and bronchopulmonary dysplasia. Environ Int 89–90:228–34

    Article  PubMed  Google Scholar 

  19. Phtalates contenus dans les médicaments: adaptation de la dose journalière admissible. J Swissmedic [in press]

  20. Horel S (2016) Perturbateurs endocriniens: la fabrique d’un mensonge. Le Monde [Internet] (novembre 29); Available from: http://www.lemonde.fr/planete/article/2016/11/29/perturbateursendocriniens- la-fabrique-d-un-mensonge_5039862_3244.html

    Google Scholar 

  21. Fischer Fumeaux CJ, Stadelmann Diaw C, Palmero D, et al (2015) Phthalate exposure in the neonatal intensive care unit. Arch Pediatr 22:203–10

    Article  CAS  PubMed  Google Scholar 

  22. ANSM (2015) Contrôle du marché des dispositifs médicaux en PVC annoncés sans DEHP. Available from: http://ansm.sante.fr

    Google Scholar 

  23. Genay S, Luciani C, Décaudin B, et al (2011) Experimental study on infusion devices containing polyvinyl chloride: to what extent are they di(2-ethylhexyl)phthalate-free? Int J Pharm 412:47–51

    Article  CAS  PubMed  Google Scholar 

  24. Pak VM, Briscoe V, McCauley LA (2006) How to reduce DEHP in your NICU: a plan of simple steps to promote change. Neonatal Netw 25:447–9

    Article  PubMed  Google Scholar 

  25. Van Vliet EDS, Reitano EM, Chhabra JS, et al (2011) A review of alternatives to di(2-ethylhexyl)phthalate-containing medical devices in the neonatal intensive care unit. J Perinatol 31:551–60

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de néonatologie, département femme-mère–enfant, Centre hospitalier universitaire Vaudois (CHUV) et université de Lausanne, Maternité - Ci03/122, 2, avenue Pierre-Decker, CH-1011, Lausanne, Suisse

    C. J. Fischer Fumeaux, M. Bickle Graz, C. Stadelmann Diaw, D. Palmero & J. -F. Tolsa

  2. Unité de développement, service de néonatologie, département femme-mère–enfant, Centre hospitalier universitaire Vaudois, université de Lausanne, Lausanne, 1011, Suisse

    M. Bickle Graz

  3. École de pharmacie Lausanne-Genève, section des sciences pharmaceutiques, Université de Lausanne et Université de Genève, Genève, Suisse

    D. Palmero

  4. Service de pharmacie, Centre hospitalier universitaire Vaudois, Lausanne, Suisse

    D. Palmero

Authors
  1. C. J. Fischer Fumeaux
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Bickle Graz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Stadelmann Diaw
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Palmero
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. -F. Tolsa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. J. Fischer Fumeaux.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fischer Fumeaux, C.J., Bickle Graz, M., Stadelmann Diaw, C. et al. Exposition aux produits chimiques dans les unités de soins néonatals — Exemple des phtalates. Rev. med. perinat. 9, 87–92 (2017). https://doi.org/10.1007/s12611-017-0412-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12611-017-0412-1

Mots clés

Keywords

Search

Navigation